If you want the fundamentals, start with our B12 injections overview
BPC-157 and TB-500 (thymosin -4) are research compounds with no approved human or veterinary drug product
Doubled Mortality Rates in Breast Cancer Patients Using B12 In breast cancer patients , Vitamin B12 supplements during chemo have been linked to doubled mortality rates
In animal studies, typically involving rats and mice, doses range from 0.1 to 10 micrograms per kilogram of body weight, administered via intramuscular, subcutaneous, or oral routes
*RESULTS GIVEN IN TESTIMONIALS ARE FROM REAL CUSTOMERS, BUT SIMILAR RESULTS ARE NOT GUARANTEED
Available long-term data: Limited data beyond 12 weeks of continuous use No long-term safety concerns identified in available data Both peptides are based on naturally occurring compounds Theoretical profile favorable for extended use Long-term recommendations: Consider cycling on and off for very extended use Enhanced monitoring for protocols beyond 12 weeks Periodic assessment of continued need Documentation of long-term outcomes Theoretical long-term concerns: No major concerns identified Both peptides work with natural healing processes No evidence of tolerance or dependence No withdrawal effects on discontinuation Comparison to Alternative Treatments The safety profile compares favorably to alternatives